Minerva Net Receivables vs Net Tangible Assets Analysis
NERV Stock | USD 2.39 0.12 4.78% |
Minerva Neurosciences financial indicator trend analysis is infinitely more than just investigating Minerva Neurosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Minerva Neurosciences is a good investment. Please check the relationship between Minerva Neurosciences Net Receivables and its Net Tangible Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
Net Receivables vs Net Tangible Assets
Net Receivables vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Minerva Neurosciences Net Receivables account and Net Tangible Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Minerva Neurosciences' Net Receivables and Net Tangible Assets is 0.46. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Minerva Neurosciences, assuming nothing else is changed. The correlation between historical values of Minerva Neurosciences' Net Receivables and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Minerva Neurosciences are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Net Receivables i.e., Minerva Neurosciences' Net Receivables and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.46 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Net Receivables
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Minerva Neurosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to 0.00 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.68) in 2024.
2023 | 2024 (projected) | Extraordinary Items | 8.5M | 7.5M | Reconciled Depreciation | 29.6K | 57.8K |
Minerva Neurosciences fundamental ratios Correlations
Click cells to compare fundamentals
Minerva Neurosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Minerva Neurosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 77.5M | 57.6M | 77.1M | 55.1M | 56.9M | 88.0M | |
Other Current Liab | (41.2B) | 2.1M | 965.7K | 407.9K | 1.5M | 1.6M | |
Total Current Liabilities | 6.6M | 3.2M | 2.8M | 1.4M | 3.3M | 4.4M | |
Total Stockholder Equity | 27.8M | 52.7M | 8.0M | (20.0M) | (28.5M) | (27.0M) | |
Net Debt | (21.1M) | (25.2M) | (60.8M) | 37.6M | 41.0M | 43.1M | |
Retained Earnings | (286.7M) | (284.8M) | (334.7M) | (366.8M) | (396.8M) | (377.0M) | |
Cash | 21.4M | 25.4M | 60.8M | 36.1M | 41.0M | 34.7M | |
Cash And Short Term Investments | 45.9M | 25.4M | 60.8M | 36.1M | 41.0M | 51.4M | |
Common Stock Total Equity | 3.9K | 3.9K | 3.9K | 4.3K | 4.9K | 3.0K | |
Common Stock Shares Outstanding | 4.9M | 5.1M | 5.3M | 5.3M | 6.5M | 4.6M | |
Liabilities And Stockholders Equity | 77.5M | 57.6M | 77.1M | 55.1M | 56.9M | 88.0M | |
Other Current Assets | 1.3B | 2.1B | 1.4B | 4.0M | 989.9K | 940.4K | |
Other Stockholder Equity | 314.5M | 337.5M | 342.7M | 346.8M | 368.4M | 264.5M | |
Total Liab | 49.7M | 5.0M | 69.1M | 75.1M | 85.4M | 42.7M | |
Total Current Assets | 47.1M | 27.4M | 62.2M | 40.2M | 42.0M | 52.9M | |
Common Stock | 3.9K | 4K | 4.3K | 534.0 | 699.0 | 664.05 | |
Property Plant And Equipment Net | 278K | 101.8K | 51.1K | 16.3K | 10.9K | 10.3K | |
Accounts Payable | 2.3M | 995.6K | 1.9M | 969.7K | 1.8M | 1.5M | |
Non Current Assets Total | 30.4M | 30.2M | 14.9M | 14.9M | 14.9M | 27.9M | |
Non Current Liabilities Total | 43.1M | 1.8M | 66.3M | 73.7M | 82.0M | 41.8M | |
Property Plant And Equipment Gross | 278.0K | 101.8K | 0.0 | 16.3K | 18.8K | 17.8K | |
Short Term Debt | 4.0M | (41.2B) | 173K | 111.2K | 100.1K | 105.1K | |
Property Plant Equipment | 33.5K | 16.0K | 101.8K | 16.3K | 18.8K | 36.8K | |
Other Liab | 43.0M | 1.8M | 66.3M | 73.7M | 84.8M | 89.0M | |
Net Tangible Assets | (2.3M) | 22.6M | (6.9M) | (34.9M) | (31.4M) | (29.9M) | |
Retained Earnings Total Equity | (164.4M) | (214.6M) | (286.7M) | (284.8M) | (256.3M) | (269.1M) | |
Capital Surpluse | 296.0M | 304.8M | 314.5M | 337.5M | 388.1M | 278.9M | |
Non Current Liabilities Other | 41.2M | 41.3M | 66.3M | 73.7M | 82.0M | 41.9M | |
Net Invested Capital | 27.8M | 52.7M | 8.0M | (20.0M) | (28.5M) | (27.0M) | |
Net Working Capital | 40.5M | 24.3M | 59.4M | 38.8M | 38.7M | 46.9M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Return On Assets (0.30) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.